30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Neuroone Medical Technologies Corp (NMTC)

Track

Over the last 90 days, Neuroone Medical Technologies Corp. has seen a net insider selling of $11,368.62, primarily from Business Development Director Mark Christianson. This activity occurred against a backdrop of a 26.5% stock price decrease over the same period. The company's last earnings report missed expectations by 8.43%.
Stock chart
Ticker: NMTC Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Christianson Mark
Business Development Director
1 sale — total 11,369 USD
Sale 30 Mar 2026
Value US$4,211,119.81 | Price 60.13 | Shares 11,914
Sale 13 Mar 2026
Value US$3,571,300.64 | Price 468.05 | Shares 51,116
Sale 12 Mar 2026
Value US$653.60 | Price 0.80 | Shares 817
Sale 11 Mar 2026
Value US$1,687.20 | Price 0.80 | Shares 2,109
Sale 11 Mar 2026
Value US$1,687.20 | Price 0.80 | Shares 2,109
Sale 10 Mar 2026
Value US$9,288.80 | Price 0.80 | Shares 11,611
Sale 10 Mar 2026
Value US$9,288.80 | Price 0.80 | Shares 11,611
Proposed sale 9 Mar 2026
Value US$25,200.00 | Price 0.84 | Shares 30,000
Buy 1 Mar 2026
Value US$670,400.00 | Price 0.67 | Shares 1,000,000
Sale 5 Sep 2025
Value US$22,203.00 | Price 0.74 | Shares 30,000
Proposed sale 20 Aug 2025
Value US$24,210.00 | Price 0.81 | Shares 30,000
Sale 4 Jun 2025
Value US$5,804.00 | Price 0.58 | Shares 10,000
Sale 22 May 2025
Value US$5,586.44 | Price 0.62 | Shares 8,967
Sale 21 May 2025
Value US$9.10 | Price 0.65 | Shares 14
Sale 20 May 2025
Value US$1,975.93 | Price 0.66 | Shares 3,013
Sale 19 May 2025
Value US$5,329.59 | Price 0.67 | Shares 8,006
Buy 4 Apr 2025
Value US$100,000.00 | Price 0.50 | Shares 200,000
Buy 4 Apr 2025
Value US$50,000.00 | Price 0.50 | Shares 100,000
Proposed sale 14 Mar 2025
Value US$30,600.00 | Price 1.02 | Shares 30,000
Sale 6 Jun 2024
Value US$1,917.56 | Price 0.88 | Shares 2,189
Sale 5 Jun 2024
Value US$22,662.72 | Price 0.88 | Shares 25,800
Proposed sale 24 May 2024
Value US$32,700.00 | Price 1.09 | Shares 30,000
Sale 27 Dec 2023
Value US$45,859.39 | Price 1.46 | Shares 31,445
Sale 26 Dec 2023
Value US$9,269.45 | Price 1.35 | Shares 6,848
Sale 22 Dec 2023
Value US$2,520.00 | Price 1.40 | Shares 1,800
Buy 21 Dec 2023
Value US$105,000.00 | Price 1.40 | Shares 75,000
Sale 21 Dec 2023
Value US$13,869.80 | Price 1.40 | Shares 9,907
Proposed sale 21 Dec 2023
Value US$69,000.00 | Price 1.38 | Shares 50,000
Buy 13 Sep 2023
Value US$50,024.52 | Price 0.98 | Shares 50,900
Sale 23 Mar 2023
Value US$19,091.92 | Price 1.50 | Shares 12,711
Sale 22 Mar 2023
Value US$17,599.67 | Price 1.51 | Shares 11,667
Sale 21 Mar 2023
Value US$3,405.39 | Price 1.60 | Shares 2,122
Buy 15 Jun 2022
Value US$10,219.00 | Price 1.02 | Shares 10,000
Buy 10 Jun 2022
Value US$14,781.20 | Price 1.06 | Shares 14,000
Buy 24 May 2022
Value US$10,291.05 | Price 0.98 | Shares 10,500
Buy 20 May 2022
Value US$14,924.00 | Price 0.85 | Shares 17,500
Sale 12 Jun 2020
Value US$200,400.00 | Price 0.60 | Shares 334,000
Sale 1 Mar 2018
Value US$249,999.20 | Price 1.10 | Shares 227,272
Buy 19 May 2017
Value US$501.72 | Price 0.03 | Shares 15,728
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-01 2026-03-30 S Sale
3.2
Christianson Mark

Business Development Director

Officer
11,914 +17.1%
60.13
US$4,211,120 		11,914 +17.1% 60.13 US$4,211,120
2026-03-16 2026-03-13 S Sale
3.2
Christianson Mark

Business Development Director

Officer
51,116 -32.7%
468.05
US$3,571,301 		51,116 -32.7% 468.05 US$3,571,301
2026-03-16 2026-03-12 S Sale
3.2
Christianson Mark

Business Development Director

Officer
81,569 -43.4%
150.37
US$494,770 		81,569 -43.4% 150.37 US$494,770
2026-03-12 2026-03-11 S Sale
3.2
Christianson Mark

Business Development Director

Officer
2,109 -1.0%
0.80
US$1,687 		2,109 -1.0% 0.80 US$1,687
2026-03-12 2026-03-11 S Sale
3.2
Christianson Mark

Business Development Director

Officer
2,109 -1.0%
0.80
US$1,687 		2,109 -1.0% 0.80 US$1,687
2026-03-12 2026-03-10 S Sale
3.2
Christianson Mark

Business Development Director

Officer
11,611 -5.1%
0.80
US$9,289 		11,611 -5.1% 0.80 US$9,289
2026-03-12 2026-03-10 S Sale
3.2
Christianson Mark

Business Development Director

Officer
11,611 -5.1%
0.80
US$9,289 		11,611 -5.1% 0.80 US$9,289
2026-03-09 2026-03-09 PrS Proposed sale
3.2
Christianson Mark

Officer

Officer
30,000
0.84
US$25,200 		30,000 0.84 US$25,200
2026-03-03 2026-03-01 B Purchase
3.7
Wambeke David J.

Chief Business Officer

Officer
1,000,000 +inf%
0.67
US$670,400 		1,000,000 +inf% 0.67 US$670,400
2025-09-09 2025-09-05 S Sale
3.2
Christianson Mark

Business Development Director

Officer
30,000 -11.5%
0.74
US$22,203 		30,000 -11.5% 0.74 US$22,203
2025-08-20 2025-08-20 PrS Proposed sale
3.2
Christianson Mark

Officer

Officer
30,000
0.81
US$24,210 		30,000 0.81 US$24,210
2025-06-05 2025-06-04 S Sale
3.2
Christianson Mark

Business Development Director

Officer
10,000 -3.7%
0.58
US$5,804 		10,000 -3.7% 0.58 US$5,804
2025-05-23 2025-05-22 S Sale
3.2
Christianson Mark

Business Development Director

Officer
8,967 -3.2%
0.62
US$5,586 		8,967 -3.2% 0.62 US$5,586
2025-05-23 2025-05-21 S Sale
3.2
Christianson Mark

Business Development Director

Officer
14 -0.0%
0.65
US$9 		14 -0.0% 0.65 US$9
2025-05-21 2025-05-20 S Sale
3.2
Christianson Mark

Business Development Director

Officer
3,013 -1.1%
0.66
US$1,976 		3,013 -1.1% 0.66 US$1,976
2025-05-21 2025-05-19 S Sale
3.2
Christianson Mark

Business Development Director

Officer
8,006 -2.7%
0.67
US$5,330 		8,006 -2.7% 0.67 US$5,330
2025-04-07 2025-04-04 B Purchase
4.0
McClurg Ronald W.

Chief Financial Officer

Officer
200,000 +81.9%
0.50
US$100,000 		200,000 +81.9% 0.50 US$100,000
2025-04-07 2025-04-04 B Purchase
3.3
Rosa David A

CEO and President

Executive Director
100,000 +9.4%
0.50
US$50,000 		100,000 +9.4% 0.50 US$50,000
2025-03-14 2025-03-14 PrS Proposed sale
3.2
Christianson Mark

Co-Founder, VP of Business Communication,Affiliate
30,000
1.02
US$30,600 		30,000 1.02 US$30,600
2024-06-11 2024-06-06 S Sale
3.2
Christianson Mark

Business Development Director

Officer
2,189 -0.7%
0.88
US$1,918 		2,189 -0.7% 0.88 US$1,918
2024-06-07 2024-06-05 S Sale
3.2
Christianson Mark

Business Development Director

Officer
25,800 -8.0%
0.88
US$22,663 		25,800 -8.0% 0.88 US$22,663
2024-05-24 2024-05-24 PrS Proposed sale
3.2
Christianson Mark

co-founder, VP of Business Communication, Affiliat
30,000
1.09
US$32,700 		30,000 1.09 US$32,700
2023-12-27 2023-12-27 S Sale
3.2
Christianson Mark

Business Development Director

Officer
31,445 -9.5%
1.46
US$45,859 		31,445 -9.5% 1.46 US$45,859
2023-12-27 2023-12-26 S Sale
3.2
Christianson Mark

Business Development Director

Officer
6,848 -2.0%
1.35
US$9,269 		6,848 -2.0% 1.35 US$9,269
2023-12-26 2023-12-22 S Sale
3.2
Christianson Mark

Business Development Director

Officer
1,800 -0.5%
1.40
US$2,520 		1,800 -0.5% 1.40 US$2,520
2023-12-26 2023-12-21 B Purchase
1.3
Volker Christopher

Chief Operating Officer

Officer
75,000 +inf%
1.40
US$105,000 		75,000 +inf% 1.40 US$105,000
2023-12-26 2023-12-21 S Sale
3.2
Christianson Mark

Business Development Director

Officer
9,907 -2.8%
1.40
US$13,870 		9,907 -2.8% 1.40 US$13,870
2023-12-21 2023-12-21 PrS Proposed sale
3.2
Christianson Mark

Officer

Officer
50,000
1.38
US$69,000 		50,000 1.38 US$69,000
2023-09-14 2023-09-13 B Purchase
4.0
McClurg Ronald W.

Chief Financial Officer

Officer
50,900 +64.0%
0.98
US$50,025 		50,900 +64.0% 0.98 US$50,025
2023-03-24 2023-03-23 S Sale
3.2
Christianson Mark

Business Development Director

Officer
12,711 -3.6%
1.50
US$19,092 		12,711 -3.6% 1.50 US$19,092
2023-03-24 2023-03-22 S Sale
3.2
Christianson Mark

Business Development Director

Officer
11,667 -3.2%
1.51
US$17,600 		11,667 -3.2% 1.51 US$17,600
2023-03-24 2023-03-21 S Sale
3.2
Christianson Mark

Business Development Director

Officer
2,122 -0.6%
1.60
US$3,405 		2,122 -0.6% 1.60 US$3,405
2022-06-16 2022-06-15 B Purchase
4.0
McClurg Ronald W.

Chief Financial Officer

Officer
10,000 +17.5%
1.02
US$10,219 		10,000 +17.5% 1.02 US$10,219
2022-06-14 2022-06-10 B Purchase
4.0
McClurg Ronald W.

Chief Financial Officer

Officer
14,000 +32.6%
1.06
US$14,781 		14,000 +32.6% 1.06 US$14,781
2022-05-24 2022-05-24 B Purchase
4.0
McClurg Ronald W.

Chief Financial Officer

Officer
10,500 +32.3%
0.98
US$10,291 		10,500 +32.3% 0.98 US$10,291
2022-05-24 2022-05-20 B Purchase
4.0
McClurg Ronald W.

Chief Financial Officer

Officer
17,500 +116.7%
0.85
US$14,924 		17,500 +116.7% 0.85 US$14,924
2020-06-16 2020-06-12 S Sale
3.2
Christianson Mark

VP of Market Development

Officer
334,000 -23.5%
0.60
US$200,400 		334,000 -23.5% 0.60 US$200,400
2018-03-05 2018-03-01 S Sale Fredrickson Wade Large shareholder
227,272 -8.0%
1.10
US$249,999 		227,272 -8.0% 1.10 US$249,999
2017-07-14 2017-05-19 B Purchase Samad Amer

Chief Executive Officer

Executive Director Large shareholder
15,728 +0.4%
0.03
US$502 		15,728 +0.4% 0.03 US$502
Explore more

More insider trading research around Neuroone Medical Technologies Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America